Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Irina Pulyakhina
    Member
    • Sep 2010
    • 24

    #1

    Varscan output contains dots

    Hi guys,

    I'm using VarScan v 2.3.7 to call SNPs in Illumina Hiseq2000 RNA-Seq paired-end sample:

    > samtools mpileup -B -Q 0 -f reference.fa $CONTROL.bam > sample.mpileup
    > java -jar VarScan mpileup2cns $sample.mpileup --min-coverage 10 --min-reads2 3 --strand-filter 0 --output-vcf 1 > sample.vcf

    What I get a lot is columns that contain dots at a position of the variance:
    chr1 155979352 . A . . PASS ADP=464;WT=1;HET=0;HOM=0;NC=0 GT:GQ:SDPP:RD:AD:FREQ:PVAL:RBQ:ABQ:RDF:RDR:ADF:ADR 0/0:666:536:464:448:14:3.03%:5.523E-5:37:34:315:133:14:0

    When I check the reads in UCSC, I can see 448 A (reference allele), 14 G (alternative allele) and no other nucleotides. I'm not sure why, instead of reporting "G", Varscan reports a dot as a variance.

    Does anyone have an explanation for this?

    Thanks in advance!

    Cheers,
    Irina
  • yueluo
    Member
    • Aug 2013
    • 82

    #2
    3% variant frequency does not pass the default minimum variant frequency for Varscan, which is 0.2(20%) for "mpileup2cns". You can change the threshold with '--min-var-freq' option.

    Comment

    • nnutter
      Junior Member
      • Mar 2013
      • 6

      #3
      This question was cross-posted on Biostars.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 08-06-2026, 07:41 AM
      0 responses
      15 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Working...